Elisa Pirro
Ospedale San Luigi Gonzaga(IT)University of Turin(IT)
Publications by Year
Research Areas
Hemoglobinopathies and Related Disorders, Chronic Myeloid Leukemia Treatments, Iron Metabolism and Disorders, Chronic Lymphocytic Leukemia Research, Antifungal resistance and susceptibility
Most-Cited Works
- → New HPLC–MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma(2009)114 cited
- → Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children(2017)56 cited
- → A New HPLC-UV Validated Method for Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in Leukemic Patients(2011)51 cited
- → Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane(2013)43 cited
- → A new HPLC UV validated method for therapeutic monitoring of deferasirox in thalassaemic patients(2012)35 cited
- → Pharmacogenetic of Voriconazole Antifungal Agent in Pediatric Patients(2018)33 cited
- → A new simple HPLC method for measuring mitotane and its two principal metabolites(2006)30 cited
- → Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children(2017)21 cited
- → Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection(2017)19 cited
- → Preclinical pharmacokinetics comparison between resveratrol 2-hydroxypropyl-β-cyclodextrin complex and resveratrol suspension after oral administration(2016)17 cited